Skip to main content

COLGATE PALMOLIVE CO

corporate_fare Company Profile

COLGATE PALMOLIVE CO

CL·NYSE·Consumer Defensive·CIK 0000021665

Colgate-Palmolive Company operates in two product segments: Oral, Personal and Home Care, and Pet Nutrition. The company markets its products in over 200 countries and territories globally. Founded in 1806 and incorporated in Delaware in 1923, Colgate-Palmolive is a leader in Oral Care, holding global leadership in the toothpaste and manual toothbrush categories based on market share data. Its toothpaste brands include Colgate, Darlie, elmex, hello, meridol, Sorriso, and Tom's of Maine. Toothbrushes are sold under brands such as Colgate, Darlie, elmex, and meridol, while mouthwashes include Colgate, elmex, and meridol. The Oral Care business also provides pharmaceutical products for dentists and other oral health professionals. The company focuses on leveraging its global brand reach, science-based innovation, omni-channel demand generation, and capabilities in data, analytics, and artificial intelligence.

COLGATE PALMOLIVE CO (NYSE:CL) is a publicly traded company in the Consumer Defensive sector. Wiseek monitors CL SEC EDGAR filings and licensed market news in real time, scoring each submission for market-moving significance on a 1–10 scale. Items rated 7 or higher generate instant alerts.

Recent high-impact activity:

  • Colgate's Q1 Operating Profit Falls to $964M, Gross Margin Declines as Pet-Food Exit Weighs
  • Colgate-Palmolive Posts 2.2% Global Pricing Growth in Q1
  • Colgate-Palmolive Appoints Bristol Myers Squibb CEO to Board
  • Annual Report Reveals 23% Drop in Operating Profit and Significant $919M Impairment Charge on Skin Health Business
  • Reports Q4 & FY2025 Results with Significant Skin Health Impairment; Issues 2026 Guidance

Financial Snapshot

Fiscal year ended December 31, 2025
Revenue
$20.38B
Net Income
$2.13B
Diluted EPS
$2.63
Op. Cash Flow
$4.2B
Free Cash Flow
$3.63B
Gross Profit
$12.25B
Operating Income
$3.31B
Cash & Equivalents
$1.29B
Total Debt
$7.99B
Debt / Equity
147.89×
Net Margin
10.5%
Shares Outstanding
801.24M sh
Source: 10-K · filed 2026-02-23 · accession 0000021665-26-000006
Browse all tickers starting with C →
$89.59 +0.14% today
52-week range · as of 2026-03-12 $74.55 – $99.33
Market cap
$71.58B
Volume
3.7M (0.7× avg)
3-mo avg 5.3M
Live data · 2026-06-14 03:50 UTC · Market closed

show_chartPrice Chart

Loading chart...

feed CL - Latest Insights

CL
May 01, 2026, 4:06 PM EDT
Source: Wiseek News
Importance Score:
8
Colgate's Q1 Operating Profit Falls to $964M, Gross Margin Declines as Pet-Food Exit Weighs
Price at Filing: $87.00
Real-time Price: $89.59 info
Change: +$2.59 (+3%) info
Market Cap: $71.577B info
Sentiment: Negative
View Wiseek Article
CL
May 01, 2026, 6:55 AM EDT
Source: Dow Jones Newswires
Importance Score:
7
Colgate-Palmolive Posts 2.2% Global Pricing Growth in Q1
Price at Filing: $86.00
Real-time Price: $89.59 info
Change: +$3.59 (+4%) info
Market Cap: $71.577B info
Sentiment: Positive
View Wiseek Article
CL
Mar 12, 2026, 4:33 PM EDT
Filing Type: 8-K
Importance Score:
7
Colgate-Palmolive Appoints Bristol Myers Squibb CEO to Board
Price at Filing: $87.80
Real-time Price: $89.59 info
Change: +$1.79 (+2%) info
Market Cap: $71.577B info
Sentiment: Positive
View Wiseek Article
CL
Feb 23, 2026, 4:03 PM EST
Filing Type: 10-K
Importance Score:
8
Annual Report Reveals 23% Drop in Operating Profit and Significant $919M Impairment Charge on Skin Health Business
Price at Filing: $97.10
Real-time Price: $89.59 info
Change: -$7.51 (-8%) info
Market Cap: $71.577B info
Sentiment: Negative
View Wiseek Article
CL
Jan 30, 2026, 7:57 AM EST
Filing Type: 8-K
Importance Score:
8
Reports Q4 & FY2025 Results with Significant Skin Health Impairment; Issues 2026 Guidance
Price at Filing: $86.85
Real-time Price: $89.59 info
Change: +$2.74 (+3%) info
Market Cap: $71.577B info
Sentiment: Negative
View Wiseek Article